Publications
Broutian TR, Jiang B, Li J, Akagi K, Gui S, Zhou Z, Xiao W, Symer DE, Gillison ML. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma. Cancer Lett 2020 Apr 28; 476:23-33. Epub 2020 Jan 17. Cancer Lett. 2020. PMCID: PMC7239795
Gillison ML, Akagi K, Xiao W, Jiang B, Pickard RKL, Li J, Swanson BJ, Agrawal AD, Zucker M, Stache-Crain B, Emde AK, Geiger HM, Robine N, Coombes KR, Symer DE. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res 2019: 29 (1): 1-17. PMCID: PMC6314162
Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 2019; 393(10166): 40-50. PMCID: PMC6541928
Tota JE, Best AF, Zumsteg ZS, Gillison ML, Rosenberg PS, Chaturvedi AK. Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. J Clin Oncol 2019: 37(18): JCO1900370: Epub ahead of print. PMCID: PMC6599405
Chaturvedi AK, Graubard BI, Broutian T, Xiao W, Pickard RKL, Kahle L, Gillison ML. Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016. JAMA 2019: 322 (10): 977-979. PMCID: PMC6737522
Gillison ML, Blumenschein G, Jr., Fayette J, et al. CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. Oncologist 2018; 23(9): 1079-82. PMCID: PMC6221824
Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong ZY, Xiao W, Kahle L, Gillison ML. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States. J Clin Oncol 36(3): JCO2017750141, 1/2018. e-Pub 11/2017. PMCID: PMC5773841
Harrington KJ, Ferris RL, Blumenschein G, Jr., et al. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol 2017; 18(8): 1104-15. PMCID: PMC6461049
Ferris RL, Blumenschein G, Jr., Fayette J, et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med 2016; 375(19): 1856-67. PMCID: PMC5564292
Gillison ML, Chaturvedi A, Anderson WF, Fakhry C. The epidemiology of HPV-positive head and neck squamous cell carcinoma. J Clin Oncol 2015. 33: 3235. PMCID: PMC4979086
Chaturvedi A, Graubard B, Broutian T, Pickard R, Tong Z, Xiao W, Kahle L, Gillison ML. NHANES 2009–2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men. Cancer Res. 2015 Jun 15;75(12):2468-77. E-pub 2015 Apr 14. PMCID: PMC4470779
Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiand B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Reid T, Symer DE, Gillison ML. Genome-Wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 2014; 24(2): 185-99. PMCID: PMC3912410
Fakhry C, Zhang Q, Nguyen-Tan P, Rosenthal DI, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avinosis V, Ridge JA, Harris J, Le Q, Gillison ML. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 2014; Accompanied by editorial. PMCID: PMC4195851
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J. Clin. Oncol. 2013 31 (36) 4550-9. PMCID: PMC3865341
Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of Oral HPV Infection in the United States, 2009-2010. JAMA. 2012; 307(7): 693-703. Accompanied by editorial. PMCID: PMC5790188
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang, B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. J Clin Oncol. 2011; 29(32): 4294-301. Accompanied by editorial. PMCID: PMC3221528
Ang KK, Harris J, Westra WH, Chung CH, Jordan RC, Rosenthal DI, Nguyen-Tan PF, Spanos WJ, Redmond KP, Gillison ML. Human papillomavirus (HPV) and survival of patients with oropharynx cancer. New England J Med. 2010; 363(1): 24-35. Accompanied by editorial. PMCID: PMC2943767
Gillison ML, D’souza G. Westra WH, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for HPV-positive and negative head and neck squamous cell carcinoma. J Natl Cancer Inst. 2008; 100: 407-20. PMID: 18334711.
D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal carcinoma. N Engl J Med. 2007; 356: 1944-56. Accompanied by editorial. PMID: 17494927.